Skip to Main Content

Advertisement

Skip Nav Destination

An Embarrassment of Riches: Three FDA-Approved Bispecific Antibodies for Relapsed Refractory Multiple Myeloma

Blood Cancer Discov (2023) 4 (6): 433–436.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Toshiki Ochi
  • Tatsuya Konishi
  • Katsuto Takenaka
International Journal of Hematology (2024)
  • Laura Díez-Alonso
  • Aïda Falgas
  • Javier Arroyo-Ródenas
  • Paola A. Romencín
  • Alba Martínez
  • Marina Gómez-Rosel
  • Belén Blanco
  • Anaïs Jiménez-Reinoso
  • Andrea Mayado
  • Alba Pérez-Pons
  • Óscar Aguilar-Sopeña
  • Ángel Ramírez-Fernández
  • Alejandro Segura-Tudela
  • Lorena Perez-Amill
  • Antonio Tapia-Galisteo
  • Carmen Domínguez-Alonso
  • Laura Rubio-Pérez
  • Maria Jara
  • Francesc Solé
  • Oana Hangiu
  • Laura Almagro
  • Ángela Albitre
  • Petronila Penela
  • Laura Sanz
  • Eduardo Anguita
  • Antonio Valeri
  • Almudena García-Ortiz
  • Paula Río
  • Manel Juan
  • Joaquín Martínez-López
  • Pedro Roda-Navarro
  • Beatriz Martín-Antonio
  • Alberto Orfao
  • Pablo Menéndez
  • Clara Bueno
  • Luis Álvarez-Vallina
Science Translational Medicine (2024) 16 (734)
  • Andreas Papapetropoulos
  • Stavros Topouzis
  • Steve P. H. Alexander
  • Miriam Cortese‐Krott
  • Dave A. Kendall
  • Kirill A. Martemyanov
  • Claudio Mauro
  • Nithyanandan Nagercoil
  • Reynold A. Panettieri
  • Hemal H. Patel
  • Rainer Schulz
  • Barbara Stefanska
  • Gary J. Stephens
  • Mauro M. Teixeira
  • Nathalie Vergnolle
  • Xin Wang
  • Péter Ferdinandy
British Journal of Pharmacology (2024)
  • Elie Dolgin
Nature Cancer (2023) 4 (12): 1612.
Close Modal

or Create an Account

Close Modal
Close Modal